He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...

Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered royalties on Ziihera until fully repaidZymeworks to retain ...

ADCs integrate monoclonal antibodies with cytotoxic payloads, offering new treatment options for NSCLC, including biomarker-selected and biomarker-agnostic patients. ADCs are composed of an antibody, ...

Therapeutic antibodies, especially polyclonal antibodies, are indispensable in contemporary medicine for addressing a broad spectrum of conditions, including infectious diseases, autoimmune disorders, ...

ObjectivesThe aim of the present study was to compare the differences in clinical outcomes within 6 months postoperatively between a complement-dependent cytotoxicity <10% group of low-risk kidney ...

Abstract: The complement-dependent cytotoxicity (CDC) assay is the criterion (gold) standard for detecting antihuman leukocyte antigen antibodies. Conventional cell classification techniques like ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. FcγRI plays a crucial role in the effector function of IgG antibodies, interacting ...